Synucleinopathies exhibit significance clinical and pathological heterogeneity, characterized by disease-specific variations in clinical manifestations, progression rates, and the specific brain regions and cell types susceptible to α-synuclein accumulation and subsequent cellular degeneration [27,101]. Here, SNCA is linked to synucleinopathy.